جست‌وجوی استاد و پژوهشگر

• Lymphoma
• Hodgkin Lymphoma
• Non-Hodgkin Lymphoma
• +۵ مورد دیگر

Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.

Tianxi Caiمشاهده پروفایل

استاد

• Biomedical Informatics
• Biostatistics
• Machine Learning
• +۷ مورد دیگر

Tianxi Cai, ScD, holds the John Rock Professorship in Population and Translational Data Sciences at the Harvard T.H. Chan School of Public Health and is a Professor of Biomedical Informatics at Harvard Medical School. She directs the Translational Data Science Center for a Learning Health System (CELEHS). Her work bridges clinical and basic science data to advance personalized medicine and disease understanding. Institution: Harvard University Departments: Biostatistics (T.H. Chan School) and Biomedical Informatics (HMS) Key Roles: Faculty member since 2002, NIH-funded researcher, and leader in EHR data analytics Research focuses on biomarker evaluation, predictive modeling, high-dimensional data analysis, and survival analysis. Collaborates with the I2B2 Center to integrate clinical and genomic data. Active in developing semi-supervised learning methods for noisy EHR data and real-world evidence generation. Funding : Recent grants include NIH projects on rheumatoid arthritis treatment response (R01AR080193, R21AR078339) and semi-supervised EHR denoising (R01LM013614). Co-leads initiatives on chronic disease endpoints using multi-source data (U01FD007929). Labs/Teams : Directs CELEHS and leads the Cai Lab, focusing on translational data science and machine learning applications in healthcare.

Vishal Ahujaمشاهده پروفایل

دانشیار

• Healthcare Operations
• Operations Management
• Service Operations
• +۷ مورد دیگر

Vishal Ahuja is an Associate Professor and Corrigan Research Professor at Southern Methodist University's Cox School of Business, with adjunct faculty status at University of Texas Southwestern Medical Center. He focuses on decision analytic tools for healthcare improvement through operations management. PhD, University of Chicago Booth School of Business MBA, University of Chicago Booth School of Business His research interests span healthcare operations, service optimization, and AI applications in clinical decision-making. He collaborates with the Department of Veterans Affairs, Parkland Hospital, and pediatric institutions to address care quality and delivery efficiency. Recent publications emphasize predictive modeling for chronic disease management, adaptive clinical trial design, and regulatory healthcare policy. Awards include the Dlin/Fischer Clinical Research Award (2021), INFORMS Pierskalla Award (2012), and 2025 AI75 recognition for Dallas-Fort Worth AI leadership. D CEO Excellence in Healthcare Award - Outstanding Healthcare Innovator (2023) NSF Game Changer Academies for Advancing Research Innovation (2022) C. Jackson Grayson Faculty Innovation Award (2022-23) At SMU, he teaches graduate courses in operations, supply chain, and service management, integrating corporate sector experience from chemical and consumer goods industries. His work has been cited by the FDA in safety labeling changes workshops.

Ben Seiyon Leeمشاهده پروفایل

استادیار

• Computational Statistics
• Spatiotemporal Modeling
• Climate Change Impact Analysis
• +۳ مورد دیگر

Ben Seiyon Lee is an Assistant Professor in the Department of Statistics at George Mason University's College of Science. His work bridges computational statistics, climate modeling, and environmental risk assessment. Education: PhD in Statistics, Pennsylvania State University (2020) Lee specializes in computational methods for high-dimensional spatiotemporal data and uncertainty quantification in climate models. His research explores climate change impacts on extreme hydrological events, wildfire emissions, and medical decision-making. Recent publications focus on Bayesian spatiotemporal frameworks for extreme precipitation analysis, zero-inflated spatial models, and multisector uncertainty quantification. His work addresses challenges in flood risk assessment, agricultural yield projections, and healthcare compliance metrics.

Su Ryon Shinمشاهده پروفایل

استادیار

• Bioengineering
• Tissue Engineering
• 3D Bioprinting
• +۷ مورد دیگر

Dr. Su Ryon Shin is an Assistant Professor in the Division of Engineering in Medicine at Harvard Medical School and Brigham and Women's Hospital (BWH) in Cambridge, MA. She leads an active research laboratory focused on bioengineering, tissue engineering, and regenerative medicine, with particular expertise in 3D bioprinting, biomaterials, and organ-on-a-chip technology. Her research interests span biohybrid robotics, decellularized extracellular matrix, stem cell-based tissue engineering, and volumetric muscle regeneration . Dr. Shin's work integrates advanced biomaterials with cellular systems to create innovative solutions for tissue regeneration and disease modeling. She has pioneered approaches using human stem cell-derived materials for volumetric tissue regeneration and developed biohybrid neuromuscular robots powered by living cardiac muscle cells. Her publication record demonstrates consistent productivity with over 180 publications, including numerous first/senior author papers in high-impact journals like Science Robotics, Advanced Materials, and Nature Reviews Bioengineering . Her work shows a clear progression from fundamental biomaterials development to increasingly complex tissue engineering applications and translational research. Dr. Shin has received significant recognition including being named a 2025 BWH Health & Technology Innovation Awardee , Highly Cited Researcher 2024 by Web of Science, and multiple Stepping Strong Innovator Awards (2015, 2018, 2020). Her research has been featured in Nature Reviews Bioengineering for breakthrough work on biohybrid robots. She actively mentors students and postdocs, with former lab members accepted to prestigious programs like MIT's PhD program in Chemical Engineering. Her collaborative approach is evident through numerous interdisciplinary projects with researchers across Harvard Medical School, BWH, and international institutions.

Steff Lewisمشاهده پروفایل

استاد

• Medical Statistics
• Clinical Trials
• Epidemiology
• +۳ مورد دیگر

Steff Lewis is a Professor of Medical Statistics at the University of Edinburgh , affiliated with the Usher Institute within the College of Medicine and Veterinary Medicine . She leads the statistics group at the Edinburgh Clinical Trials Unit and holds roles in the Deanery of Molecular, Genetic and Population Health Sciences . Her expertise spans meta-analysis, randomized trial design, and clinical trial governance, with involvement in Cochrane Collaboration and UK Clinical Research Collaboration initiatives. Education: MSc and PhD in Medical Statistics. Research Interests: Focuses on methodological advancements in clinical trial reporting (e.g., CONSORT and SPIRIT guidelines), cardiovascular outcomes (e.g., SCOT-HEART trial), stroke prevention (ASPIRING trial), and ethical data management. She actively contributes to international standards for trial protocols, anonymization practices, and statistical validation. Recent Contributions: Over 200 peer-reviewed articles and 37 ongoing projects, including leadership in trials assessing antiplatelet therapies, Paget’s disease interventions, and pediatric asthma treatments. Collaborates globally on guidelines for randomized trials and data-sharing protocols. Grants & Teams: Principal or co-investigator on projects funded by NIHR, BHF, and ESRC, including trials on iron therapy in critical care (INTACT-2) and cannabinoid treatments for endometriosis pain (ENDO-CAN). Leads multidisciplinary teams integrating statistical rigor with clinical innovation. Labs/Teams: Embedded within the Edinburgh Clinical Trials Unit and the Centre for Population Health Sciences , fostering collaborative research across molecular, genetic, and public health domains.

• Cardiac Surgery
• Heart Valve Disease
• Transcatheter Valve Interventions
• +۷ مورد دیگر

Francesco Maisano, MD , is Full Professor of Cardiac Surgery at Vita-Salute San Raffaele University (Milan) since 2021, where he also serves as Director of the Cardiac Surgery Clinic and of the Valve Center at IRCCS San Raffaele Hospital. From 2014 to 2020 he held the Chair of Cardiac Surgery and directed the Department at University Hospital Zurich. Education & Training 1990 – MD, Catholic University of Rome 1994 – Clinical Fellowship, University of Alabama at Birmingham 1995 – Specialization in Cardiac Surgery, La Sapienza University of Rome Research Interests Professor Maisano’s work centres on innovative therapies for heart-valve disease, spanning surgical reconstruction, catheter-based interventions (TAVI, MitraClip, transcatheter tricuspid devices), and hybrid approaches. He leads translational programmes in biomedical engineering, multimodality cardiac imaging, and artificial-intelligence-guided interventions, with emphasis on the multidisciplinary “Heart Team” model for complex cardiovascular disease. His recent publications (2024-2025) demonstrate intense activity in transcatheter mitral and tricuspid repair, long-term durability of surgical mitral repair, AI-driven procedural guidance, and renal protection strategies during mechanical circulatory support. A dominant theme is translating imaging innovations and device concepts into first-in-human studies and large-scale registries. Scientific Awards & Recognitions European Society of Cardiology Silver Medal (2018) ICI Lifetime Achievement in Research & Teaching (2018) ICI Best Technology Parade Presentation (2010) C. Walton Lillehei Young Investigator Award (1999) Leadership & Grants He directs multiple postgraduate programmes, including Certificate of Advanced Studies (CAS) tracks at the University of Zurich in multimodality imaging, aortic valve, and mitral–tricuspid interventions. He is principal investigator on investigator-initiated grants, coordinates industry-partnered device trials, and mentors numerous doctoral and post-doctoral researchers. His team has filed >24 patents and spun off several cardiovascular start-ups. Labs & Teams At IRCCS San Raffaele he leads the Valve Science Center , a multidisciplinary hub integrating cardiac surgeons, interventional cardiologists, imaging specialists, biomedical engineers, and data scientists focused on next-generation valve repair/replacement technologies and personalised cardiovascular medicine.

• Cardiothoracic Surgery
• Heart Valve Repair and Replacement
• Cardiac Imaging
• +۳ مورد دیگر

DE BONIS MICHELE is a Professor at San Raffaele Vita-Salute University , where he serves as the Director of the Cardiothoracic Surgery School. He is also the Chief of the Advanced and Research Cardiothoracic Surgery Unit at Ospedale San Raffaele , actively contributing to clinical and academic advancements in cardiovascular surgery since 2017. Research Interests : His work focuses on complex cardiac surgical techniques, including mitral and tricuspid valve repair, transcatheter interventions, and management of complications like pseudoaneurysms and thrombotic events. His recent publications highlight innovations in cardioplegia delivery, CT imaging for endocarditis, and outcomes of surgical and transcatheter approaches. Scientific Awards and Leadership : He has received notable awards such as the Premio "Eccellenze Lucane" (2018), Premio Nazionale Ciociaria (2005), and Premio di Medicina "Prof. Potito Petrone" (1995). He has held key roles in international societies, including President of the European Society of Cardiology's Cardiovascular Surgery Working Group (2014-2016) and Scientific Director of ESC/EACTS guidelines task forces. Teaching and Editorial Contributions : He supervises internships in surgery and cardiovascular diseases for the 6-year Master's Degree in Medicine and Surgery. He also serves as Editor-in-Chief and editorial board member for the International Journal of Cardiology .

Pierre Jaïsمشاهده پروفایل

استاد

• Cardiac Arrhythmias
• Atrial Fibrillation
• Catheter Ablation
• +۶ مورد دیگر

Prof. Pierre Jaïs serves as University Professor in Cardiology and Cardiac Electrophysiology at the University of Bordeaux and Head of the Electrophysiology Unit at Bordeaux University Hospital. He concurrently leads the Electrophysiology and Heart Modeling Institute (LIRYC) as CEO since 2021, driving innovation in cardiac rhythm disorder treatments through multidisciplinary research. His research revolutionized cardiac electrophysiology by identifying pulmonary veins as primary sources of atrial fibrillation, establishing pulmonary vein isolation as the global treatment standard. Current work focuses on pulsed field ablation—a non-thermal technique with potential to replace conventional ablation—and developing advanced imaging for precise arrhythmia targeting, reflecting his commitment to translating scientific discovery into clinical solutions. Analysis of recent publications (2017-2021) reveals dominant trends in pulsed field ablation optimization, comparative ablation techniques, and AI integration in cardiovascular imaging. These works consistently address atrial fibrillation treatment efficacy, safety profiles, and technological innovation, positioning him at the forefront of electrophysiology advancement. His distinguished contributions are recognized through prestigious awards including: 2019: Eli S. Gang Most Innovative Abstract Award (Heart Rhythm Society) 2018: Eric N. Prystowsky Lectureship Award 2012: Academy of Medicine Membership (Paris) 2009: Circulation Best Paper Award Multiple National Academy of Medicine honors Prof. Jaïs actively mentors electrophysiology trainees and secures substantial research funding, notably leading an EU-funded randomized trial comparing pulsed field versus thermal ablation. His LIRYC institute integrates cardiology, engineering, and computational expertise to accelerate therapeutic innovation. The LIRYC institute operates as a collaborative hub where clinicians, biomedical engineers, and data scientists develop next-generation electrophysiology tools. Current projects include real-time arrhythmia mapping systems, tissue-selective ablation protocols, and AI-driven predictive models for treatment personalization, fostering seamless translation from bench to bedside.

Mehmet Karahanمشاهده پروفایل

دانشیار

• Cardiovascular Surgery
• Cardiac Surgery
• Mechanical Circulatory Support
• +۴ مورد دیگر

Mehmet Karahan is an Associate Professor in the Department of Cardiovascular Surgery at Gaziantep University Faculty of Medicine. He specializes in cardiovascular surgery with a focus on mechanical circulatory support, left ventricular assist devices (LVAD), heart transplantation, and endovascular procedures. His clinical and research work centers on innovative approaches to treating complex cardiac conditions. His educational background includes: Medical License (English Program): Hacettepe University Faculty of Medicine (2004-2011), Turkey Specialization in Cardiovascular Surgery: Health Sciences University, Ankara High Specialized Health Application and Research Center (2012-2017), Turkey Dr. Karahan's research interests span multiple areas within cardiovascular medicine. He has made significant contributions to the field of mechanical circulatory support, particularly focusing on left ventricular assist devices (LVAD) and their applications in both adult and pediatric patients. His work explores minimally invasive approaches to LVAD implantation, management of complications, and integration with other cardiac procedures. Additionally, he has expertise in endovascular aortic repair techniques, including complex cases involving traumatic injuries and challenging anatomies. His research also extends to heart transplantation, anticoagulation management, and thrombophilia in vascular disease. Analysis of Dr. Karahan's recent publications reveals a strong focus on advancing mechanical circulatory support technologies, particularly LVAD systems. His work addresses critical challenges in the field including pediatric applications, minimally invasive techniques, management of complications like pump thrombosis, and integration with other cardiac procedures. He has also made significant contributions to endovascular aortic repair, developing innovative techniques for complex cases. His research demonstrates a multidisciplinary approach that bridges surgical innovation with patient-centered outcomes. Dr. Karahan is an active member of several professional organizations: European Association for Cardio-Thoracic Surgery (EACTS) - Member since 2024 International Society for Heart and Lung Transplantation (ISHLT) - Member since 2023 National Association of Vascular and Endovascular Surgery - Member since 2020 Turkish Cardiovascular Surgery Association - Member since 2014 He has served as an editor for The Turkish Journal of Thoracic and Cardiovascular Surgery (2025). His clinical work involves complex cardiovascular procedures, with a particular emphasis on innovative approaches to mechanical circulatory support and endovascular interventions. Dr. Karahan has presented his research at numerous national and international conferences, contributing to the advancement of cardiovascular surgical techniques. His professional experience includes positions at Gaziantep University, Ankara Bilkent City Hospital, and Turkey High Specialization Hospital. He has also gained international experience through observer positions at Paracelsus Medical University-Nuremberg Clinic, Hannover Medical School, University of Geneva, and Harvard University.

Eldrin F. Lewisمشاهده پروفایل

استاد

• Heart Failure
• Cardiovascular Medicine
• Quality of Life Assessment
• +۴ مورد دیگر

Eldrin F. Lewis, MD, MPH is the Simon H. Stertzer, MD, Professor of Medicine and Chief of the Division of Cardiovascular Medicine at Stanford University School of Medicine. He holds a University Medical Line Professorship within the Department of Medicine - Cardiovascular Medicine and is a member of the Cardiovascular Institute. Dr. Lewis earned his medical degree from the Perelman School of Medicine at the University of Pennsylvania (1995), completed his Internal Medicine Residency (1998), Cardiovascular Disease Fellowship (2001), and Heart Transplant Fellowship (2002), all at Brigham and Women's Hospital in Massachusetts. He maintains board certification in Cardiovascular Disease (2024) and Advanced Heart Failure and Transplant Cardiology (2025) through the American Board of Internal Medicine. As an internationally recognized expert in heart failure, heart transplant, and quality of life for heart failure patients, Dr. Lewis' research focuses on patient-reported outcomes, quality of life assessment, and the integration of digital health technologies into cardiovascular care. His fundamental principle is that "there is more to life than death," emphasizing that cardiovascular care should help patients not only survive but also enjoy the best possible quality of life. His extensive publication record includes nearly 200 peer-reviewed articles in top journals including the New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, JAMA Cardiology, and JAMA Internal Medicine. His recent work (2024-2025) demonstrates strong focus on heart failure treatment optimization, diversity in clinical trials, pulmonary congestion assessment, and the implementation of quadruple medical therapy for heart failure patients. Joel Gordon Miller Award for community service and leadership from the University of Pennsylvania School of Medicine Minority Faculty Development Award recognizing research potential of young physicians Robert Wood Johnson Foundation grant for quality of life assessment research Fellow of the American College of Cardiology Member of the American Heart Association Research Committee Dr. Lewis serves as a Postdoctoral Faculty Sponsor for Phenesse Dunlap and has received significant research support from the National Heart, Lung and Blood Institute, National Institutes of Health, and the Robert Wood Johnson Foundation. He is deeply committed to expanding clinical research initiatives at Stanford, forming partnerships with community cardiologists, and leveraging Silicon Valley's digital technology expertise for patient monitoring and treatment optimization. His leadership includes serving on the AHA Founders Affiliate Board of Directors, chairing the Council on Clinical Cardiology, and participating in the FDA Task Force for Standardization of Definitions for Endpoint Events in Cardiovascular Trials.

Krishnan Bhaskaranمشاهده پروفایل

استاد

• Cancer epidemiology
• Statistical epidemiology
• Pharmacoepidemiology
• +۵ مورد دیگر

Krishnan Bhaskaran is a Professor of Statistical Epidemiology at the London School of Hygiene & Tropical Medicine (LSHTM) , affiliated with the Faculty of Epidemiology and Population Health and the Department of Non-communicable Disease Epidemiology . He leads the Beyond Cancer research group , supported by a Wellcome Senior Research Fellowship . He co-founded the OpenSAFELY platform for real-time pandemic data analysis. Education: Background in Mathematics and Medical Statistics Research Interests: Cancer survivorship, cardiovascular and mental health outcomes in cancer survivors, pharmacoepidemiology of drug interactions, and methodological advancements in electronic health records analysis Publication Trends: His recent work focuses on long-term health consequences of cancer and its treatments, drug interactions in cardiovascular therapies, and the impact of chronic conditions on cancer risk. Many studies utilize large UK datasets and the OpenSAFELY platform. Scientific Awards: Wellcome Senior Research Fellowship Grants & Leadership: He has secured major funding from Cancer Research UK , British Heart Foundation , and Wellcome Trust to investigate cardiovascular risks post-cancer, health inequalities in endocrine therapy adherence, and drug safety in anticoagulant use.

• Health services research
• Implementation science
• Patient-reported outcomes
• +۶ مورد دیگر

Rachel Hess, MD, MS is Professor of Population Health Sciences and Internal Medicine and Associate Vice President for Research-Health Sciences at the University of Utah Schools of the Health Sciences. She co-directs the Utah Clinical and Translational Science Institute and was founding Chief of the Division of Health System Innovation and Research (2014-2022). A board-certified General Internist and internationally recognized health-services researcher, she focuses on translating evidence into practice through health-information technology and patient-centered outcomes. Education & Training MD – University of New Mexico School of Medicine MS Clinical Research – University of Pittsburgh Fellowship – General Internal Medicine & Women’s Health, University of Pittsburgh / VA Pittsburgh Medical Center Chief Residency – Internal Medicine, Western Pennsylvania Hospital Residency – Internal Medicine, Temple University Hospital BA Mathematics – Washington University in St. Louis Research Focus Dr Hess’s program is dedicated to improving patient-centered outcomes by leveraging implementation science, health-information technology, and patient-reported measures. Her work spans: Design and nationwide deployment of EHR-integrated clinical decision support for cancer genetics, lung-cancer screening, heart-failure management, and antibiotic stewardship. Large multi-site pragmatic trials (ADAPTABLE, RECOVER, BRIDGE, MAINTAIN) examining effectiveness, equity, and scalability of digital-health interventions. Women’s health across the lifespan, including studies on menopause, sexual function, and post-COVID sequelae. Advanced analytics linking patient-reported outcomes (PROs) with healthcare utilization and cost. Scientific Awards & Recognition Board Certification, American Board of Internal Medicine (Internal Medicine) Leadership of NIH RECOVER Consortium adult cohort—one of the largest studies of Long COVID worldwide Principal investigator on >$50 million in federal and foundation funding (PCORI, NHLBI, NCI, AHRQ, CDC) Leadership & Service As Associate Vice President for Research she sets strategic priorities for the Schools of Medicine, Nursing, Pharmacy, Dentistry, and Health. She co-chairs the Utah Clinical and Translational Science Institute, oversees campus-wide clinical-trials infrastructure, and mentors interdisciplinary teams spanning informatics, behavioral science, epidemiology, and clinical medicine. Laboratories & Teams Dr Hess leads the Health System Innovation and Research (HSIR) group—an interdisciplinary unit of data scientists, implementation researchers, clinicians, and patient partners—dedicated to rapid-cycle testing and national scale-up of digital-health solutions.

• Pediatric Critical Care
• Pediatric Endocrinology
• Diabetic Ketoacidosis
• +۴ مورد دیگر

Michael S.D. Agus, M.D. is the Constantine Anast, MD Professor of Pediatrics at Boston Children's Hospital, which is affiliated with Harvard Medical School. He serves in the Department of Pediatrics with a focus on critical care and endocrinology. Dr. Agus is a prominent researcher in pediatric critical care medicine, with particular expertise in glycemic control, diabetic ketoacidosis, and sepsis management in critically ill children. Dr. Agus's research interests center around optimizing care for critically ill children, with a strong focus on glucose management in pediatric intensive care settings. His work has significantly contributed to understanding the optimal blood glucose ranges for critically ill children, the management of diabetic ketoacidosis in pediatric patients, and the role of corticosteroids in pediatric septic shock. He has led several major NIH-funded clinical trials including the HALF-PINT (Heart and Lung Failure-Pediatric INsulin Titration) trial and the SHIPSS (Stress Hydrocortisone In Pediatric Septic Shock) study. Dr. Agus has been instrumental in developing clinical guidelines for glycemic control in critically ill children, as evidenced by his contributions to the Society of Critical Care Medicine Guidelines. His research employs advanced methodologies including transcriptomics to identify subclasses of pediatric septic shock, potentially enabling more personalized treatment approaches. His work bridges the gap between critical care medicine and endocrinology, focusing on how metabolic management affects outcomes in critically ill children. Dr. Agus has received significant recognition for his research, with numerous high-impact publications in leading medical journals including Critical Care Medicine , Pediatric Critical Care Medicine , and The Lancet Child & Adolescent Health . His work on glycemic control has been particularly influential in shaping clinical practice for critically ill children with diabetes or hyperglycemia. As a principal investigator on multiple NIH grants, Dr. Agus leads a robust research program focused on improving outcomes for critically ill children. His work extends beyond direct patient care to include healthcare systems research, examining optimal staffing models in pediatric intensive care units and building global collaborative research networks in pediatric critical care. He is actively involved in translating research findings into clinical practice through guideline development and educational initiatives.

Michael Stevensمشاهده پروفایل

مدرس ارشد

• Biomedical Engineering
• Advanced Manufacturing
• Digital Manufacturing
• +۶ مورد دیگر

Dr. Michael Stevens is a Senior Lecturer at University of New South Wales (UNSW) Canberra , where he focuses on advanced manufacturing and biomedical device control systems . His work bridges digital manufacturing for SMEs with smart artificial heart technologies , emphasizing industry collaboration and translational research. Specializes in physiological control systems for rotary blood pumps Develops unobtrusive fall detection systems for dementia patients Leads international projects on total artificial heart development Education : B.Eng (Medical - First Class Honours), Queensland University of Technology (2010) PhD in Physiological Control for Biventricular Assist Devices, University of Queensland (2014) Research Trends show consistent focus on: Machine learning for biomedical diagnostics (2018–2025) mmWave radar and thermal sensors in patient monitoring (2021–2024) Computational fluid dynamics in artificial heart modeling (2016–2024) Physiological control algorithms for rotary blood pumps (2011–2025) Scientific Awards : UNSW Scientia Education Award (2021) for contextual teaching Heart Foundation Runner-up for "Smart Artificial Hearts" pitch (2021) ARC PGC Supervisor Award (2017) for mentoring Grants & Supervision : Holds over $6 million in competitive funding including MRFF and ARC grants. Currently supervises 4 PhD students while maintaining industry partnerships with VitalCare and BiVACOR. Labs & Facilities : Works across UNSW Engineering labs and Graduate School of Biomedical Engineering platforms, including mock circulation loops and high-performance computing clusters for CFD simulations.